University of California San Francisco

Publications

  1. Leukotriene B4: A potential mediator and biomarker for cardiac allograft vasculopathy.
    2024 | PubMed
  2. Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate.
    2024 | PubMed
  3. Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity.
    2023 | PubMed
  4. Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques.
    2023 | PubMed
  5. Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice.
    2023 | PubMed
  6. Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice.
    2023 | PubMed
  7. Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression.
    2023 | PubMed
  8. Author Correction: Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
    2022 | PubMed
  9. Hypoimmune induced pluripotent stem cell-derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice.
    2021 | PubMed
  10. Immunomodulation Therapy Using Tolerogenic Macrophages in a Rodent Model of Pulmonary Hypertension.
    2021 | PubMed
  11. The SIRPα-CD47 immune checkpoint in NK cells.
    2021 | PubMed
  12. Comprehensive Multi-omics Analysis Reveals Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact.
    2020 | PubMed
  13. The H-Y Antigen in Embryonic Stem Cells Causes Rejection in Syngeneic Female Recipients.
    2020 | PubMed
  14. A Cryoinjury Model to Study Myocardial Infarction in the Mouse.
    2019 | PubMed
  15. De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans.
    2019 | PubMed
  16. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
    2019 | PubMed
  17. Dead space ventilation promotes alveolar hypocapnia reducing surfactant secretion by altering mitochondrial function.
    2019 | PubMed
  18. Exosomal profiling in cardiac allograft rejection: Best basic science article in 2018.
    2018 | PubMed
  19. No effect of thymosin beta-4 on the expression of the transcription factor Islet-1 in the adult murine heart.
    2018 | PubMed
  20. Sphingosine-1-phosphate receptor 1 regulates neointimal growth in a humanized model for restenosis.
    2018 | PubMed
  21. Optimization of oxygenation during ex vivo lung perfusion-Best basic science article in 2017.
    2018 | PubMed
  22. Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta.
    2018 | PubMed
  23. Opportunities for Lung Repair and Regeneration: An Overview.
    2017 | PubMed
  24. Thalidomide treatment prevents chronic graft rejection after aortic transplantation in rats - an experimental study.
    2017 | PubMed
  25. Differences in Vascular Response between Balloon Overstretch and Stent Overexpansion in Nonatherosclerotic Porcine Coronary Arteries.
    2017 | PubMed
  26. The ubiquitin-proteasome system: A potential therapeutic target for heart failure.
    2017 | PubMed
  27. Vein Interposition Model: A Suitable Model to Study Bypass Graft Patency.
    2017 | PubMed
  28. Orthotopic tracheal transplantation using human bronchus: an original xenotransplant model of obliterative airway disorder.
    2016 | PubMed
  29. miR-126: a potential new key player in hypoxia and reperfusion?
    2016 | PubMed
  30. The Selective JAK1/3-Inhibitor R507 Mitigates Obliterative Airway Disease Both With Systemic Administration and Aerosol Inhalation.
    2016 | PubMed
  31. "Bioengineered lungs" Best science paper in JHLT 2014-2015.
    2016 | PubMed
  32. miR-21 promotes fibrosis in an acute cardiac allograft transplantation model.
    2016 | PubMed
  33. Sex Differences in Immunology: More Severe Development of Experimental Pulmonary Hypertension in Male Rats Exposed to Vascular Endothelial Growth Factor Receptor Blockade.
    2015 | PubMed
  34. Alagebrium inhibits neointimal hyperplasia and restores distributions of wall shear stress by reducing downstream vascular resistance in obese and diabetic rats.
    2015 | PubMed
  35. Distal Airway Stem Cells are Essential for Lung Regeneration.
    2015 | PubMed
  36. Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis.
    2015 | PubMed
  37. Advancing knowledge of right ventricular pathophysiology in chronic pressure overload: Insights from experimental studies.
    2015 | PubMed
  38. Effective Apical Infection of Differentiated Human Bronchial Epithelial Cells and Induction of Proinflammatory Chemokines by the Highly Pneumotropic Human Adenovirus Type 14p1.
    2015 | PubMed
  39. Mesenchymal stromal cell therapy: different sources exhibit different immunobiological properties.
    2015 | PubMed
  40. Immunobiology of fibrin-based engineered heart tissue.
    2015 | PubMed
  41. Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.
    2015 | PubMed
  42. Erratum: miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development.
    2015 | PubMed
  43. SCNT-derived ESCs with mismatched mitochondria trigger an immune response in allogeneic hosts.
    2014 | PubMed
  44. miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development.
    2014 | PubMed
  45. Inducing myointimal hyperplasia versus atherosclerosis in mice: an introduction of two valid models.
    2014 | PubMed
  46. Dichloroacetate prevents restenosis in preclinical animal models of vessel injury.
    2014 | PubMed
  47. The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy.
    2013 | PubMed
  48. Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue.
    2013 | PubMed
  49. Small animal models of experimental obliterative bronchiolitis.
    2013 | PubMed
  50. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
    2013 | PubMed
  51. Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545.
    2012 | PubMed
  52. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    2012 | PubMed
  53. Human internal mammary artery (IMA) transplantation and stenting: a human model to study the development of in-stent restenosis.
    2012 | PubMed
  54. Localization of Islet-1-positive cells in the healthy and infarcted adult murine heart.
    2012 | PubMed
  55. Human leukocyte antigen I knockdown human embryonic stem cells induce host ignorance and achieve prolonged xenogeneic survival.
    2011 | PubMed
  56. Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells.
    2011 | PubMed
  57. Assessment of physiologic natural killer cell cytotoxicity in vitro.
    2011 | PubMed
  58. Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo.
    2011 | PubMed
  59. Bioluminescence imaging for assessment of immune responses following implantation of engineered heart tissue (EHT).
    2011 | PubMed
  60. Prevention of transplant coronary artery disease by prenylation inhibitors.
    2011 | PubMed
  61. Orthotopic aortic transplantation: a rat model to study the development of chronic vasculopathy.
    2010 | PubMed
  62. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.
    2010 | PubMed
  63. Sustained inhibition of epsilon protein kinase C inhibits vascular restenosis after balloon injury and stenting.
    2010 | PubMed
  64. Non-volume-loaded heart provides a more relevant heterotopic transplantation model.
    2010 | PubMed
  65. Heterotopic and orthotopic tracheal transplantation in mice used as models to study the development of obliterative airway disease.
    2010 | PubMed
  66. Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation.
    2009 | PubMed
  67. LAD-ligation: a murine model of myocardial infarction.
    2009 | PubMed
  68. Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium.
    2009 | PubMed
  69. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
    2009 | PubMed
  70. Imaging in-stent restenosis: an inexpensive, reliable, and rapid preclinical model.
    2009 | PubMed
  71. A novel JAK3 inhibitor, R348, attenuates chronic airway allograft rejection.
    2009 | PubMed
  72. Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart.
    2009 | PubMed
  73. In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation.
    2008 | PubMed
  74. Comparison of different adult stem cell types for treatment of myocardial ischemia.
    2008 | PubMed
  75. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.
    2008 | PubMed
  76. Novel immunosuppression: R348, a JAK3- and Syk-inhibitor attenuates acute cardiac allograft rejection.
    2008 | PubMed
  77. Prevention and inhibition but not reversion of chronic allograft vasculopathy by FK778.
    2008 | PubMed
  78. Introducing the first polymer-free leflunomide eluting stent.
    2008 | PubMed
  79. Inhibition of aldehyde dehydrogenase type 2 attenuates vasodilatory action of nitroglycerin in human veins.
    2008 | PubMed
  80. Failed induction of heme oxygenase 1 in endothelial cells exposed to the hemoglobin based oxygen carrier Oxyglobin.
    2008 | PubMed
  81. Right atrial mass after primary repair of an atrial septal defect: thrombus masquerading as a myxoma.
    2007 | PubMed
  82. Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?
    2007 | PubMed
  83. Coincidence of aortic valve stenosis and regurgitation and multiple cardiac papillary fibroelastomas in a young male adult.
    2007 | PubMed
  84. Simplified protocol to isolate, purify, and culture expand mesenchymal stem cells.
    2007 | PubMed
  85. Experimental orthotopic tracheal transplantation: The Stanford technique.
    2007 | PubMed
  86. FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.
    2007 | PubMed
  87. Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?
    2006 | PubMed
  88. The selective estrogen receptor-beta agonist biochanin A shows vasculoprotective effects without uterotrophic activity.
    2006 | PubMed
  89. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase.
    2006 | PubMed
  90. Sirolimus and FK778: a comparison of two anti-proliferative immunosuppressants for prevention of experimental obliterative airway disease.
    2006 | PubMed
  91. The phytoestrogen biochaninA weakens acute cardiac allograft rejection without affecting the reproductive system.
    2005 | PubMed
  92. FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantation.
    2005 | PubMed
  93. FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival.
    2005 | PubMed
  94. FK778 attenuates lymphocyte-endothelium interaction after cardiac transplantation: in vivo and in vitro studies.
    2004 | PubMed
  95. The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependent.
    2004 | PubMed
  96. Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation model.
    2003 | PubMed
  97. Successful resection of a symptomatic right ventricular lipoma.
    2003 | PubMed
  98. New technique for chest opening in mice: U-sternotomy.
    2003 | PubMed
  99. Myoblasts survive intracardiac transfer and divide further after transplantation.
    2002 | PubMed
  100. Wildlife ecologist: aldo leopoid.
    1988 | PubMed
  101. Clinical Improvement With Transcatheter Edge-to-Edge Tricuspid Repair Irrespective of Right Atrial Pressure.
    2024 | PubMed
  102. Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate.
    2024 | PubMed
  103. Four decades of progress in heart-lung transplantation: Two hundred seventy-one cases at a single institution.
    2024 | PubMed
  104. Lung Transplantation in Patients with Cystic Fibrosis: A Complex Task, A Changing Target.
    2023 | PubMed
  105. Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity.
    2023 | PubMed
  106. Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques.
    2023 | PubMed
  107. Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice.
    2023 | PubMed
  108. Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice.
    2023 | PubMed
  109. Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression.
    2023 | PubMed
  110. Morbidity and Mortality Associated With Blood Transfusions in Elective Adult Cardiac Surgery.
    2022 | PubMed
  111. Author Correction: Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
    2022 | PubMed
  112. Intercostal Nerve Cryoanalgesia Versus Thoracic Epidural Analgesia in Lung Transplantation: A Retrospective Single-Center Study.
    2022 | PubMed
  113. Hypoimmune induced pluripotent stem cell-derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice.
    2021 | PubMed
  114. Shock, Thrombus, TAVR: A Challenging TAVR With Large Left-Ventricular Thrombus.
    2021 | PubMed
  115. Immunomodulation Therapy Using Tolerogenic Macrophages in a Rodent Model of Pulmonary Hypertension.
    2021 | PubMed
  116. The SIRPα-CD47 immune checkpoint in NK cells.
    2021 | PubMed
  117. Outcomes of transcatheter aortic valve replacement in end stage liver and renal disease.
    2021 | PubMed
  118. Subxiphoid Hybrid Epicardial-Endocardial Atrial Fibrillation Ablation and LAA Ligation: Initial Sub-X Hybrid MAZE Registry Results.
    2020 | PubMed
  119. Impact of Aortic Stenosis on Myofiber Stress: Translational Application of Left Ventricle-Aortic Coupling Simulation.
    2020 | PubMed
  120. The H-Y Antigen in Embryonic Stem Cells Causes Rejection in Syngeneic Female Recipients.
    2020 | PubMed
  121. Risk Factors and Outcomes of Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation.
    2020 | PubMed
  122. Frailty after lung transplantation is associated with impaired health-related quality of life and mortality.
    2020 | PubMed
  123. Impact of donor lung quality on post-transplant recipient outcome in the Lung Allocation Score era in Eurotransplant - a historical prospective study.
    2020 | PubMed
  124. A Cryoinjury Model to Study Myocardial Infarction in the Mouse.
    2019 | PubMed
  125. De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans.
    2019 | PubMed
  126. Bergeyella cardium: Clinical Characteristics and Draft Genome of an Emerging Pathogen in Native and Prosthetic Valve Endocarditis.
    2019 | PubMed
  127. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
    2019 | PubMed
  128. Nontyphoidal Salmonella as a Cause of Mediastinal Abscess after Aortic Valve Replacement: A Case Report and Review of Postoperative Salmonella Infections.
    2018 | PubMed
  129. Analysis of Minimally Invasive Left Thoracotomy HVAD Implantation - A Single-Center Experience.
    2018 | PubMed
  130. Lung allocation score: the Eurotransplant model versus the revised US model - a cross-sectional study.
    2018 | PubMed
  131. Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study.
    2018 | PubMed
  132. Hybrid Open Minimally Invasive Transcatheter Mitral Valve Replacement.
    2018 | PubMed
  133. Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta.
    2018 | PubMed
  134. Hybrid and surgical procedures for the treatment of persistent and longstanding persistent atrial fibrillation.
    2018 | PubMed
  135. Outcomes of Minimally Invasive Temporary Right Ventricular Assist Device Support for Acute Right Ventricular Failure During Minimally Invasive Left Ventricular Assist Device Implantation.
    2017 | PubMed
  136. Thalidomide treatment prevents chronic graft rejection after aortic transplantation in rats - an experimental study.
    2017 | PubMed
  137. Differences in Vascular Response between Balloon Overstretch and Stent Overexpansion in Nonatherosclerotic Porcine Coronary Arteries.
    2017 | PubMed
  138. Gender differences and outcomes in left ventricular assist device support: The European Registry for Patients with Mechanical Circulatory Support.
    2017 | PubMed
  139. The value of fluorine-18 deoxyglucose positron emission tomography scans in patients with ventricular assist device specific infections†.
    2017 | PubMed
  140. Lobar lung transplantation from deceased donors: A systematic review.
    2017 | PubMed
  141. Vein Interposition Model: A Suitable Model to Study Bypass Graft Patency.
    2017 | PubMed
  142. Orthotopic tracheal transplantation using human bronchus: an original xenotransplant model of obliterative airway disorder.
    2016 | PubMed
  143. Acute Pulmonary Artery Obstruction as the Primary Manifestation of a Rapidly Growing Intimal Sarcoma in a 54-Year-Old Patient.
    2016 | PubMed
  144. A matched pairs analysis of non-rib-spreading, fully endoscopic, mini-incision technique versus conventional mini-thoracotomy for mitral valve repair.
    2016 | PubMed
  145. The Selective JAK1/3-Inhibitor R507 Mitigates Obliterative Airway Disease Both With Systemic Administration and Aerosol Inhalation.
    2016 | PubMed
  146. The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantation.
    2015 | PubMed
  147. Sex Differences in Immunology: More Severe Development of Experimental Pulmonary Hypertension in Male Rats Exposed to Vascular Endothelial Growth Factor Receptor Blockade.
    2015 | PubMed
  148. Distal Airway Stem Cells are Essential for Lung Regeneration.
    2015 | PubMed
  149. Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis.
    2015 | PubMed
  150. Mesenchymal stromal cell therapy: different sources exhibit different immunobiological properties.
    2015 | PubMed
  151. Immunobiology of fibrin-based engineered heart tissue.
    2015 | PubMed
  152. Concomitant minimally invasive HVAD and transapical aortic valve implantation.
    2015 | PubMed
  153. SCNT-derived ESCs with mismatched mitochondria trigger an immune response in allogeneic hosts.
    2014 | PubMed
  154. Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression.
    2014 | PubMed
  155. Isolated permanent right ventricular assist device implantation with the HeartWare continuous-flow ventricular assist device: first results from the European Registry for Patients with Mechanical Circulatory Support.
    2014 | PubMed
  156. Clinical experience of combined HeartWare ventricular assist device and implantable cardioverter defibrillator therapy.
    2014 | PubMed
  157. HVAD implantation in right atrium-to-right pulmonary artery configuration.
    2014 | PubMed
  158. Introduction of the lung allocation score in Germany.
    2014 | PubMed
  159. Inducing myointimal hyperplasia versus atherosclerosis in mice: an introduction of two valid models.
    2014 | PubMed
  160. Dichloroacetate prevents restenosis in preclinical animal models of vessel injury.
    2014 | PubMed
  161. Minimally invasive implantation of biventricular assist devices.
    2014 | PubMed
  162. Do not touch the sternum--thoracotomy incisions for HVAD implantation.
    2014 | PubMed
  163. Efficacy of prophylactic intra-aortic balloon pump therapy in chronic heart failure patients undergoing cardiac surgery.
    2014 | PubMed
  164. Dual-chamber pacemaker implantation with left ventricular pacing in a patient with a right ventricular assist device.
    2014 | PubMed
  165. HVAD continuous flow assist device for ischemic ventricular septal rupture.
    2014 | PubMed
  166. Mechanically induced ventricular tachycardia by the HeartWare ventricular assist device.
    2014 | PubMed
  167. Everolimus in heart transplantation: an update.
    2013 | PubMed
  168. Bortezomib rescue therapy in a patient with recurrent antibody-mediated rejection after lung transplantation.
    2013 | PubMed
  169. Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients.
    2013 | PubMed
  170. Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue.
    2013 | PubMed
  171. Minimal access median sternotomy for aortic valve replacement in elderly patients.
    2013 | PubMed
  172. Isolated permanent right ventricular assistance using the HVAD continuous-flow pump.
    2013 | PubMed
  173. Aspergillus galactomannan antigen for diagnosis and treatment monitoring in cerebral aspergillosis.
    2013 | PubMed
  174. ST-elevation myocardial infarction following heart transplantation as an unusual presentation of coronary allograft vasculopathy: a case report.
    2013 | PubMed
  175. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
    2013 | PubMed
  176. Severe bacterial superinfection based on influenza A (H1N1) pneumonia in a heart-lung transplant recipient.
    2013 | PubMed
  177. Concomitant transcatheter aortic valve and left ventricular assist device implantation.
    2013 | PubMed
  178. Late profound muscle weakness following heart transplantation due to Danon disease.
    2012 | PubMed
  179. Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545.
    2012 | PubMed
  180. Clinical and functional correlates of early microvascular dysfunction after heart transplantation.
    2012 | PubMed
  181. Successful extracorporeal membrane oxygenation weaning after cardiac resynchronization therapy device implantation in a patient with end-stage heart failure.
    2012 | PubMed
  182. Human internal mammary artery (IMA) transplantation and stenting: a human model to study the development of in-stent restenosis.
    2012 | PubMed
  183. Cardiac paraganglioma: diagnostic and surgical challenges.
    2012 | PubMed
  184. Human leukocyte antigen I knockdown human embryonic stem cells induce host ignorance and achieve prolonged xenogeneic survival.
    2011 | PubMed
  185. Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells.
    2011 | PubMed
  186. Surgical technique of lower lobe lung transplantation.
    2011 | PubMed
  187. Bioluminescence imaging for assessment of immune responses following implantation of engineered heart tissue (EHT).
    2011 | PubMed
  188. Minimally invasive resection of a right atrial mass in a cardiac transplant recipient: a case report.
    2011 | PubMed
  189. Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.
    2011 | PubMed
  190. Orthotopic aortic transplantation: a rat model to study the development of chronic vasculopathy.
    2010 | PubMed
  191. Transcatheter aortic valve implantation in a heart transplant recipient: a case report.
    2010 | PubMed
  192. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.
    2010 | PubMed
  193. Sustained inhibition of epsilon protein kinase C inhibits vascular restenosis after balloon injury and stenting.
    2010 | PubMed
  194. Review of heart-lung transplantation at Stanford.
    2010 | PubMed
  195. Non-volume-loaded heart provides a more relevant heterotopic transplantation model.
    2010 | PubMed
  196. Heterotopic and orthotopic tracheal transplantation in mice used as models to study the development of obliterative airway disease.
    2010 | PubMed
  197. Asymptomatic infection with novel influenza A/H1N1 virus in a heart transplant recipient.
    2010 | PubMed
  198. Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation.
    2009 | PubMed
  199. Changing trends in infectious disease in heart transplantation.
    2009 | PubMed
  200. LAD-ligation: a murine model of myocardial infarction.
    2009 | PubMed
  201. Alternative technique for salvage of donor lungs with insufficient atrial cuffs.
    2009 | PubMed
  202. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
    2009 | PubMed
  203. Imaging in-stent restenosis: an inexpensive, reliable, and rapid preclinical model.
    2009 | PubMed
  204. Heart-lung transplantation in situs inversus totalis.
    2009 | PubMed
  205. Right ventricular dysfunction predicts poor outcome following hemodynamically compromising rejection.
    2009 | PubMed
  206. A novel JAK3 inhibitor, R348, attenuates chronic airway allograft rejection.
    2009 | PubMed
  207. Heart transplantation in situs inversus totalis.
    2009 | PubMed
  208. Twenty-year survivors of heart transplantation at Stanford University.
    2008 | PubMed
  209. Novel immunosuppression: R348, a JAK3- and Syk-inhibitor attenuates acute cardiac allograft rejection.
    2008 | PubMed
  210. Prevention and inhibition but not reversion of chronic allograft vasculopathy by FK778.
    2008 | PubMed
  211. Introducing the first polymer-free leflunomide eluting stent.
    2008 | PubMed
  212. Fluoroscopy to assess late heart and lung perforation by a permanent ventricular pacemaker lead. A case complicated by isolated hemothorax.
    2007 | PubMed
  213. Effect of inhaled tacrolimus on cellular and humoral rejection to prevent posttransplant obliterative airway disease.
    2007 | PubMed
  214. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
    2007 | PubMed
  215. Stem cell transplantation: the lung barrier.
    2007 | PubMed
  216. Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?
    2007 | PubMed
  217. Simplified protocol to isolate, purify, and culture expand mesenchymal stem cells.
    2007 | PubMed
  218. Experimental orthotopic tracheal transplantation: The Stanford technique.
    2007 | PubMed
  219. FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.
    2007 | PubMed
  220. Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?
    2006 | PubMed
  221. The selective estrogen receptor-beta agonist biochanin A shows vasculoprotective effects without uterotrophic activity.
    2006 | PubMed
  222. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase.
    2006 | PubMed
  223. FK778: new cellular and molecular mechanisms of action.
    2006 | PubMed
  224. Sirolimus and FK778: a comparison of two anti-proliferative immunosuppressants for prevention of experimental obliterative airway disease.
    2006 | PubMed
  225. Tracheal allograft transplantation in rats: the role of different immunosuppressants on preservation of respiratory epithelium.
    2006 | PubMed
  226. The phytoestrogen biochaninA weakens acute cardiac allograft rejection without affecting the reproductive system.
    2005 | PubMed
  227. FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantation.
    2005 | PubMed
  228. FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival.
    2005 | PubMed
  229. Video and robotic-assisted minimally invasive mitral valve surgery: a comparison of the Port-Access and transthoracic clamp techniques.
    2005 | PubMed
  230. FK778 attenuates lymphocyte-endothelium interaction after cardiac transplantation: in vivo and in vitro studies.
    2004 | PubMed
  231. The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependent.
    2004 | PubMed
  232. Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation model.
    2003 | PubMed
  233. Successful resection of a symptomatic right ventricular lipoma.
    2003 | PubMed
  234. Robotically assisted coronary artery bypass surgery with the ZEUS telemanipulator system.
    2003 | PubMed
  235. Correlation between mononuclear infiltration and changes in VASP phosphorylation patterns after heterotopic cardiac transplantation in the rat.
    2003 | PubMed
  236. Early and midterm results after coronary artery bypass grafting with and without cardiopulmonary bypass: which patient population benefits the most?
    2003 | PubMed
  237. New technique for chest opening in mice: U-sternotomy.
    2003 | PubMed
  238. Midterm results and quality of life after minimally invasive vs. conventional aortic valve replacement.
    2002 | PubMed
  239. Comparison of two stabilizer concepts for off-pump coronary artery bypass grafting.
    2002 | PubMed
  240. Robotically-assisted coronary artery surgery with and without cardiopulmonary bypass - from first clinical use to endoscopic operation.
    2002 | PubMed
  241. Effect of hemodynamics on graft rejection in the heterotopic heart transplantation model.
    1998 | PubMed